Comments on: Tersan®’s KEM® data analysis shows positive results for ValiSeek VAL401 in Phase II trial for non-small cell lung cancer (NSCLC) patients https://www.elarapharma.com/arianas-kem-data-analysis-shows-positive-results-for-valiseek-val401-in-phase-ii-trial-for-non-small-cell-lung-cancer-nsclc-patients/?utm_source=rss&utm_medium=rss&utm_campaign=arianas-kem-data-analysis-shows-positive-results-for-valiseek-val401-in-phase-ii-trial-for-non-small-cell-lung-cancer-nsclc-patients The AI DRUG Development Company Tue, 14 Dec 2021 19:03:47 +0000 hourly 1 https://wordpress.org/?v=5.8.2